The PaceMate™ Blog

PaceMate™LIVE Data Utilized in Research of COVID-19 Impact on AFib Patients

Multiple PaceMate™ leaders, including medical advisory board member Dr. Prashanthan Sanders, have published studies that have examined arrhythmia burden in CIED patients monitored remotely. In a recent study published in EP Europace, Dr. Catherine O’Shea, et al., share results linking an increase in CIED patients’ atrial fibrillation episodes with regional COVID-19 prevalence.

Data from multiple CIED patient cohorts was observed and analyzed, including patient data from American hospital-based and community-based device clinics across multiple states. De-identified, aggregated study data was obtained from PaceMate™LIVE, the world’s best cardiac remote monitoring platform, which features automated bi-directional integration of all remote monitoring transmissions and alerts from all device vendors.

Researchers assessed the pandemic’s effect on occurrence of device-detected atrial arrhythmias in patients residing in states with higher COVID-19 infection numbers. The study compared frequency of AF events during a portion of the pandemic with similar data from one year prior.

PaceMate™ Data Supports Public Health

PaceMate™ is the only company in the cardiac remote monitoring space generating data insights that are immediately actionable for both clinics and research.

PaceMate™ clinic customers can query clinic data via the PaceMate™LIVE platform from day one. But datapoints from PaceMate™LIVE also give researchers opportunity to evaluate and cross-reference historical data to inform their studies.

A recent strategic data research partnership with electrophysiologists and cardiologists at the University of North Carolina School of Medicine is enabling a more comprehensive and robust follow-on study for 2016 research, utilizing de-identified, aggregated PaceMate™LIVE data to correlate 2020 election-related stressors with an increase in adverse cardiac events.

It is exciting that our work in cardiac monitoring is already making a powerful contribution to public health, and we look forward to offering our data analytics capabilities to others in the research space.

PaceMate™. TURN US ON TODAY.

Let’s talk.
JHALE@PACEMATE.COM | 1.844.4VIPMED

Meet us at the intersection of human intelligence, innovative data management, and compassionate healthcare—where we never miss a beat.™